Zoetis
Zoetis Inc. is a global leader in the animal health industry, specializing in the discovery, development, and commercialization of medicines, vaccines, and diagnostic products. The company provides a comprehensive portfolio of animal health solutions designed to predict, prevent, detect, and treat illnesses in both companion animals and livestock. Its value proposition centers on a diverse range of therapeutic areas and advanced precision animal health technologies for veterinarians and producers.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Companion Animal Products
primaryFocuses on health solutions for pets, primarily dogs, cats, and horses, driven by the increasing human-animal bond and medicalization of pet care.
Simparica, Simparica Trio, Apoquel, Cytopoint, Librela, Solensia, Revolution
Veterinarians, Pet Owners
Livestock Products
majorProvides medicines, vaccines, and genetic tests for food-producing animals including cattle, swine, poultry, fish, and sheep to ensure sustainable and healthy food supplies.
Draxxin, Excede, Spectramast, Bovi-Shield GOLD, Inforce 3
Livestock Producers, Ranchers, Dairy Farmers, Commercial Poultry Operations
Animal Health Diagnostics
moderateDevelops and sells point-of-care diagnostic instruments and consumables, as well as laboratory services for rapid disease detection.
VETSCAN, Imagyst, Witness, AlphaTRAK
Veterinary Clinics, Reference Laboratories
Segment Financials
Dogs and Cats — Revenue
View metricParasiticides — Revenue
View metricPain and sedation — Revenue
View metricCattle — Revenue
View metricSheep and other — Revenue
View metricPoultry — Revenue
View metricAnimal health diagnostics — Revenue
View metricOther Non Pharmaceuticals — Revenue
View metricBusiness Overview
Competitive Position
Zoetis is the world's largest standalone animal health company with a dominant market share across multiple species and therapeutic categories.
Geographies
Global, North America, Europe, Asia-Pacific, Latin America
Customer Segments
Veterinary Practices, Agribusiness, Retail Pet Owners
Upstream Dependencies
Raw Material Suppliers, Active Pharmaceutical Ingredient (API) Manufacturers, Contract Manufacturing Organizations
Downstream Customers
Veterinary Hospitals, Retail Pharmacies, Livestock Production Facilities, Pet Specialty Retailers
Competitors & Partners
Competitors
Idexx Laboratories
IDXX
Primary competitor in the veterinary diagnostic equipment and laboratory services market.
Merck & Co.
MRK
Operates Merck Animal Health, a major global competitor in vaccines and pharmaceuticals.
Elanco Animal Health Inc.
ELAN
Direct competitor in both companion animal and livestock therapeutic segments.
Subsidiaries
Abaxis
Developer and manufacturer of portable diagnostic instruments for veterinary point-of-care testing.
Jurox
Animal health company specializing in companion animal and livestock pharmaceuticals.
Zoetis FAQ
Common questions about Zoetis
Zoetis Inc. is a global leader in the animal health industry, specializing in the discovery, development, and commercialization of medicines, vaccines, and diagnostic products. The company provides a comprehensive portfolio of animal health solutions designed to predict, prevent, detect, and treat illnesses in both companion animals and livestock. Its value proposition centers on a diverse range of therapeutic areas and advanced precision animal health technologies for veterinarians and producers.
Zoetis (ZTS) has a market capitalization of $31.6B and trades on NYSE.
Zoetis generated $9.5B in trailing twelve-month revenue with net income of $2.7B, representing a net margin of 28.0%. Gross margin stands at 71.8%, with free cash flow of $2.2B. These figures are based on the Q1 2026 filing.
Zoetis's key competitors include IDEXX Laboratories, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, and others. These companies compete in similar markets and product categories.
Zoetis has approximately 14,100 employees.